BBC reports such as Investigation into IVF clinics in northern Cyprus after UK families given wrong sperm and “Something wasn’t right”: Wrong sperm given to UK families by IVF clinics in northern Cyprus have understandably alarmed patients exploring IVF abroad.
The concerns raised are serious and deserve close attention, especially in donor treatment, where trust, traceability, and correct identification of samples are absolutely essential. But while these cases must be taken seriously, they should not create the false impression that all IVF clinics in North Cyprus belong in the same category. It also needs to be noted that these reported cases relate to events that occurred around 15 years ago. Patients should look beyond the headlines and judge each clinic on its own standards, safeguards, and professional practices.
…almost 25% of UK patients looking for IVF treatment abroad chose North Cyprus as their preferred destination…
That wider patient perspective is important too. In “SEEKING IVF TREATMENT ABROAD: Patient Research 2024“, IVF Media Ltd. reports that almost 25% of UK patients looking for IVF treatment abroad chose North Cyprus as their preferred destination. IVF Media presents the report as the most comprehensive global study of its kind, based on 1,189 patient responses and offering detailed insight into motivations, expectations, preferences, and experiences among people pursuing fertility treatment across borders.
‘Something wasn’t right’: Wrong sperm given to UK families by IVF clinics in northern Cyprus
The recent BBC reporting on alleged donor mix-ups linked to IVF treatment in North Cyprus has understandably unsettled patients considering treatment abroad. Any suggestion that the wrong donor sperm may have been used is profoundly serious. In donor conception, trust is not a secondary issue. It sits at the heart of informed consent, medical safety, family planning, and a child’s future understanding of their origins. Follow-on reporting on the BBC investigation said that families of seven children had raised concerns, and that many of the reported cases were linked to the same doctor or associated clinics. That distinction matters, because while the allegations are grave, they should not automatically be read as a fair description of every IVF clinic in North Cyprus.
That is the first point this debate now needs. North Cyprus should not be treated as though all clinics belong in the same bucket. The impression created by recent headlines is that “IVF clinics in North Cyprus” are the problem as a whole, yet the publicly reported allegations concern particular cases and particular providers, not every clinic in the destination. As in any country, there are weaker providers and stronger providers. Patients do not choose a country in the abstract; they choose a specific clinic, a specific embryology lab, a specific medical team, and a specific set of safeguards and ethics.
Just as importantly, there is a technical point that deserves to be stated clearly at the beginning: in a professional donor-IVF programme, sperm samples should be identified and traced by a unique code, not by a donor nickname. Patient-facing aliases may be useful when browsing donor profiles, but laboratory safety depends on formal identifiers.
ESHRE’s updated IVF laboratory recommendations say reproductive cells should be uniquely identified and traceable throughout each procedural step; devices containing biological material should be labelled with a unique identification code; and where donor sperm is used, identifying information such as donor code or clinic code must be recorded.
The same guidance recommends witness double-checks or an electronic identification system at critical stages.
That distinction is not a minor administrative detail. It is one of the foundations of traceability. A nickname may be memorable and easy for patients to recognize while browsing donor catalogues, but it is not enough for laboratory identification. The safer standard is a documented chain built around the sperm bank’s donor number, the sample code, shipment paperwork, internal clinic records, and witness checks at every critical stage. When that discipline is followed, the risk of confusion is reduced. When it is not, ambiguity can enter a process where ambiguity should never exist. ESHRE guidance is clear that identity and correspondence should be verified at critical stages and supported by witnessing or electronic traceability systems.
Patients also need a more complete picture of how reputable clinics in North Cyprus actually work. Under North Cyprus regulations, clinics are required to source donor sperm from licensed external sperm banks outside the country.
For example, both Dunya IVF Clinic, Cyprus IVF Hospital and Ventus IVF Center state this explicitly: under regulations in Northern Cyprus, clinics can only import donor semen from international sperm banks and cannot accept direct individual semen donations at the clinic.
Other North Cyprus clinic materials describe the same model, explaining that donor sperm is obtained from accredited European or international sperm banks and imported under the local regulatory framework, sometimes with permits required for sending or receiving reproductive tissue.
That matters because the central question for patients is not simply whether treatment takes place in North Cyprus, Spain, Greece, or elsewhere. The real question is how a particular clinic sources donor sperm, how it verifies that the selected donor and the sample used actually correspond, what controls exist inside the laboratory, and how clearly the clinic communicates all of this before treatment begins. Geography alone does not answer those questions. Process does. Documentation does. Accountability does.
What to ask a clinic before IVF with donor sperm? Important questions.
- Which sperm bank do you work with, and is donor sperm sourced only from licensed external banks?
- How is the donor sperm identified inside the clinic: by unique donor/sample code or by alias?
- What checks do you perform to confirm that the donor selected matches the sample used for my treatment?
- What witness system do you use in the lab to prevent mix-ups?
- What documentation will I receive about the donor code, sample traceability, and treatment records?
- What medical and genetic screening has the donor undergone?
- What information about the donor will I be able to review before making a decision?
- What are the legal rules on donor anonymity, donor limits, and future access to information?
- If I want another child in the future, what can be done now to improve the chance of using the same donor again?
- If donor sperm from the same donor is not available later, how will the clinic help me understand my options?
A clinic that takes donor treatment seriously should be able to explain, in plain language, how traceability works from donor selection through to treatment day. It should be able to show that the donor profile viewed by the patient is tied to a formal donor code from the sperm bank, that the arriving shipment is checked against that code, that storage, thawing, and treatment records correspond, and that critical steps are witnessed by a second person or by an electronic witnessing system. ESHRE’s recommendations emphasize exactly those principles: unique identification, traceability, documented checks, and witness verification at key points.
That is why it is so important not to let one headline flatten an entire sector. There are clinics and doctors that fall short of expected standards in every country. There are also clinics and professionals who build their work around systems, ethics, and patient safety. The recent reporting should absolutely prompt harder questions from patients. But it should not encourage the simplistic assumption that all IVF clinics in North Cyprus operate in the same way, or that every provider there shares the same standards, leadership, or laboratory culture. The public discussion may be broad, but the cases reported publicly were not presented as evidence against every clinic in the region.
What Reputable Clinics Should be Able to Explain
To show what responsible practice should look like in reality, we asked Özgü Özün, Managing Director of Dunya IVF Clinic in Kyrenia, to answer the questions many patients are now asking about donor sperm sourcing, sample verification, traceability, and lab safety. Dunya IVF publicly says it uses RI Witness, an RFID-based system designed to track samples throughout treatment and stop the process if a mismatch is detected.
The recent BBC coverage has left many international patients worried about North Cyprus as an IVF destination. What do you think is the biggest misconception patients may now have?
First of all, my thoughts go to the children and families who were affected. An error or a mix-up is every IVF clinic’s worst nightmare globally. Clinics must always do their best to mitigate against such risks by having robust operating procedures, quality control, witnessing and traceability systems in place. I think the misconception is that this is something unique to a destination, when it is not. It is worth noting that in the last 20 years, there have been thousands of happy families who fulfilled their dreams in North Cyprus.
Many patients do not understand how donor sperm is sourced in North Cyprus. Can you explain how reputable clinics work with accredited international sperm banks?
It is actually very simple. The assisted reproduction law in North Cyprus explicitly states that only donor sperm from accredited international sperm banks can be used for sperm donation treatments. Accredited international sperm banks have strict donor selection criteria. The tests and screenings done on the sperm donor are presented to the ministry of health regarding the sperm donor along with the sperm bank’s accreditation documents. Donor sperm can only be imported after a permit is issued by our ministry of health. There are some famous sperm banks in Scandinavia that are routinely used for donor sperm import to North Cyprus. USA is of course another important option; however vast majority of donor sperm is imported from Scandinavian sperm banks. Patients also have the freedom to choose any accredited international sperm bank for their treatment in North Cyprus. In that case, we would apply for the permit on their behalf.
In donor-sperm treatment, how should samples be identified and verified inside the clinic? Why is it safer to rely on unique sperm-bank donor numbers and sample codes rather than donor nicknames or aliases
Each donor sperm straw comes with a unique identifier from sperm banks. We do not only rely on donor aliases. This helps us, if needed, to identify even the specific sperm donation date and even the specific straw of that donor with the help of the sperm bank. This detail is recorded for each patient.
Your clinic has publicly described the use of RI Witness technology. How do witness systems like this strengthen patient safety in practice?
Traditionally, before the RI witness system was invented, embryologists would rely on another embryologist to witness that correct samples were used for the patient’s treatment and avoid a potential mix-up. Now, we can use this technology in our embryology lab as an additional safeguard against human factors. The RI witness system also helps electronically record all details of the lab workflow of that specific patient. Should the system identify a potential mismatch of a patient sample it then gives an alarm. To use the RI witness system, you need to upload all patient info including name, surname, date of birth, passport number along with partner information. This way, even if there happened to be a patient with exactly the same name having treatment on the same day in the clinic, the system would still uniquely recognize the correct sample for the correct patient raising alarms if an error was about to be committed.
If patients are not yet thinking about sibling planning before treatment, what responsibility does the clinic have to raise that issue early and explain the risks of waiting until later, when the same donor may no longer be available?
For egg donation treatment we use a high number of mature oocytes to enable a high number of blastocysts. This means that the patient has a good chance of having excess embryos that can be cryopreserved for future use. This increases the chance of having a 100% sibling in the future should the patient wish to do so. The patients who undergo sperm donation treatment are encouraged to purchase or reserve more than 1 straw of the same donor.
In your view, what separates a clinic with strong governance and real safeguards from one that relies mainly on marketing?
In a sensitive field like IVF, strong governance is of utmost importance. This should be the main driver of the clinic. Long term success comes with this mentality. Patients should do their due diligence while choosing clinics as it is generally straight forward to identify clinics who are more marketing oriented. Best is to do the research and go visit the clinics personally to assess.
What would you say to patients who are now questioning whether North Cyprus can still be a trustworthy option for donor IVF?
I think it is important not to generalize the entire IVF sector of a country. Of course, the patients should do their own diligence and choose the right clinic for their family. There are world-class clinics here who publish leading research in world’s most reputable scientific journals. I believe that North Cyprus is an important destination for international patients and believe it will continue to do so.
Transparency Matters as Much as Technology
To add another perspective, we also asked Nevzat Arşan, Managing Director of Cyprus IVF Hospital, to respond to the concerns many intended parents now have about transparency, donor sourcing, documentation, and communication. Cyprus IVF Hospital publicly says it works with European Sperm Bank and Cyros International and places strong emphasis on patient-centred care and clear communication throughout treatment.
After the BBC story, many intended parents may feel anxious about donor treatment abroad. What should a reputable clinic do first to rebuild confidence?
The first responsibility of any reputable clinic is to respond with complete transparency, clear communication, and documented reassurance.
Patients must be given a clear explanation of how donor sperm is sourced, how samples are identified and traced, and what safeguards are in place at every stage of the treatment journey. This includes explaining the use of licensed external sperm banks, unique donor and sample codes, and the witnessing procedures followed within the embryology laboratory.
At Cyprus IVF Hospital, we believe confidence is rebuilt not through statements alone, but through process visibility, written documentation, and continuous patient support. Patients should feel fully informed about every step before treatment begins and throughout their journey.
What information should every patient receive in writing before beginning treatment with donor sperm?
Every patient should receive, in writing:
– the licensed sperm bank name
– the selected donor code/reference number
– the donor’s medical and genetic screening summary
– donor characteristics available under applicable regulations
– the clinic’s traceability and witness procedures
– consent forms clearly explaining donor treatment
– legal framework regarding anonymity and future access rules
– storage, future-use, and same-donor availability policies
– communication channels for any future concerns
Written consent and traceability documentation are essential because donor treatment is built on informed consent and trust.
What are the most important questions patients should now ask any clinic in North Cyprus before proceeding?
Patients should focus on process and traceability, rather than geography alone. The most important questions are:
– Which licensed sperm bank do you work with?
– Do you use unique donor/sample codes throughout the process?
– What witness or electronic traceability system do you use?
– What documentation will I receive?
– How are samples checked on arrival and before use?
– Can the clinic explain the full chain from donor selection to treatment day?
– What are the policies for future sibling treatment?
Patients should choose a clinic based on standards, systems, and governance, not only on destination.
How should clinics communicate if a patient has concerns about donor matching, documentation, or traceability?
The response must be immediate, factual, empathetic, and fully documented.
A patient concern should never be treated as a routine customer service question. It must be escalated through the clinical and management structure immediately. The clinic should provide:
– a direct patient coordinator contact
– clinical review with the medical team
– laboratory verification of records
– written clarification of donor/sample codes
– documented chain-of-custody confirmation
Most importantly, patients should never feel ignored or uncertain about where their concern stands.
What role does patient coordination and ongoing communication play for international patients travelling from the UK and other countries?
It plays a critical role. For international patients, treatment is not only medical; it is also emotional, logistical, and often time-sensitive. Strong patient coordination ensures:
– rapid communication
– clear explanation of treatment stages
– document sharing
– donor selection support
– travel and scheduling coordination
– continuous follow-up before and after treatment
At Cyprus IVF Hospital, we place significant importance on patient-centred coordination, particularly because the majority of our patients travel internationally.
For patients who already know they may want a second child in the future, what steps can a clinic take at the start of treatment to help preserve the possibility of using sperm from the same donor again?
This should be discussed at the very beginning of treatment planning. Where possible, clinics should support patients by:
– discussing additional vial reservation options
– checking availability with the sperm bank
– arranging storage where legally permitted
– documenting future sibling planning preferences
– explaining that donor availability may change over time
This early discussion is extremely important for patients who wish to preserve sibling continuity in the future. This is a very strong question for patients to raise proactively.
For patients reading dramatic headlines, what would you want them to understand about the difference between isolated allegations and the work of established, reputable clinics?
Patients should understand that it is not appropriate to generalise an entire destination or sector based on isolated allegations concerning specific cases or providers. As in every country, clinics differ significantly in terms of leadership, laboratory governance, documentation standards, and patient care philosophy. The right approach is to evaluate each clinic individually based on:
– regulatory compliance
– external partnerships
– sperm bank sourcing
– laboratory witness systems
– transparency of records
– patient communication standards
Established clinics that work with reputable international partners and strong traceability processes should be assessed on their own merits. The focus should always remain on facts, systems, and documented safeguards.
Scientific Oversight and Clinical Responsibility
To add a third expert perspective, we also asked Assoc Prof Dr Beril Yuksel from Ventus IVF Center, to address the scientific and laboratory side of donor treatment. This is an important part of the wider discussion, because patients should understand that responsible IVF care is not defined only by marketing claims or general reputation, but by the standards applied inside the lab, the quality of supervision, the handling of donor material, and the consistency of clinical protocols.
From a scientific and laboratory perspective, what are the most important safeguards that should be in place when a clinic works with donor sperm?
From a laboratory standpoint, the most critical safeguards are those that ensure traceability, identity control, and error prevention at every step. These include:
– Unique donor/sample identification systems (never relying on names or aliases in the lab)
– Double witnessing procedures (manual and/or electronic) at all critical stages
– Full traceability documentation from receipt to use
– Strict segregation and labelling protocols for donor samples
– Validated cryostorage systems with temperature monitoring and alarm systems
– Use of accredited sperm banks that comply with international screening and testing standards
– Regular staff competency assessments and SOP (Standard Operating Procedure) adherence
Together, these safeguards create a closed, auditable system where the risk of misidentification is minimized to the lowest possible level.
What role does scientific leadership play in making sure donor treatment protocols are followed consistently and safely across the clinic?
Scientific leadership – typically the Laboratory Director or Lead Embryologist – is fundamental in ensuring safety and consistency. Their role includes:
– Developing, implementing, and updating evidence-based protocols
– Ensuring staff training, certification, and ongoing competency
– Overseeing quality management systems and incident reporting
– Conducting regular audits and compliance checks
– Embedding a culture of accountability and zero tolerance for shortcuts
Strong leadership ensures that protocols are not just written, but actively followed, monitored, and continuously improved.
How should a professional IVF laboratory manage the receipt, storage, thawing, and use of donor sperm samples to reduce the risk of mismatch or human error?
A professional IVF lab should follow a strict chain-of-custody process:
- Receipt
- Verify donor sample against documentation from the sperm bank
- Log into the lab system under a unique code
- Apply internal labelling immediately
- Storage
- Store in clearly designated, segregated cryotanks
- Maintain continuous temperature monitoring and alarm systems
- Use inventory management systems to track exact location
- Thawing & Preparation
- Cross-check patient ID, donor code, and treatment plan
- Perform double witnessing (manual and/or electronic) before thawing
- Document every step in real time
- Use in Treatment
- Final identity verification at point of use (e.g., ICSI dish)
- Maintain full traceability linking patient ↔ donor code ↔ sample batch
At every stage, no single person should work unverified at critical control points.
When patients are choosing a donor, how important is it that clinical teams distinguish clearly between donor profile information used by patients and the formal sample identification used by the laboratory?
This distinction is extremely important and must be clearly explained to patients. Donor profile information (photos, characteristics, background) is used for patient selection only Laboratory identification relies exclusively on unique donor codes and sample numbers
Patients should understand that: The name or alias they see is not used in the laboratory process
All medical and laboratory procedures are tied strictly to coded identifiers
Clear separation between these two systems helps prevent confusion and reinforces trust in the process.
What internal quality-control measures should patients expect from a clinic that says it takes donor IVF seriously?
Patients should expect a robust quality management system, including:
– Double witnessing systems (preferably electronic witnessing where available or proper documentation if manual)
– Full traceability and audit trails for all gametes and embryos
– Incident reporting and risk management systems
– Routine internal and external audits
– Strict SOPs covering all donor processes
– Secure documentation and record-keeping
– Regular equipment validation and maintenance
Accreditation or alignment with international standards (e.g., ISO, ESHRE, CAP guidelines)It is worth pointing out that Ventus IVF Centre is the only clinic in North Cyprus with the CAP accreditation and our Scientific Director is ESHRE accredited
Transparency is key—clinics should be willing to explain these systems clearly and confidently.
If a patient hopes to have more than one child with the same donor in the future, how should this be discussed from the medical and planning perspective before treatment begins?
This information must be communicated proactively, both verbally and in written consent documentation, prior to initiation of treatment. Availability is determined by donor bank supply and cannot be guaranteed at a later stage. Key considerations include:
– Reserving or purchasing additional donor samples in advance
– Understanding the sperm bank’s release limits and availability policies
– Discussing family planning goals (e.g., number of children desired)
– Considering embryo creation and cryopreservation to secure genetic consistency
– Clarifying storage duration, costs, and future use policies
Clinically, this is both a logistical and emotional planning discussion, and patients should be supported in making informed, forward-looking decisions.
What Patients Should Take Away From This Story
The BBC investigation and the wider discussion around it should therefore lead to a more precise conclusion than the broad one many readers may take away at first glance. Yes, serious allegations deserve scrutiny.
Yes, affected families deserve answers.
Yes, donor conception requires the highest standards of traceability and care.
But it is not fair to place all clinics in North Cyprus into one category because of reporting centred on particular cases, a particular doctor, and associated clinics. Patients should judge clinics individually, based on donor sourcing, laboratory controls, documentation, ethics, and openness.
In the end, the lesson is not that patients should fear every clinic in North Cyprus. The lesson is that they should choose more carefully, ask better questions, and work only with providers that can demonstrate how they protect traceability from the sperm bank to the treatment room. In responsible donor IVF, safety does not begin with a slogan or a destination label. It begins with a code, a record, a witness check, and a clinic prepared to be fully accountable for every step.
